The content on this site is intended for healthcare professionals only
Dr Frank Giordano speaks to ecancer about the INTRAGO phase 3 study and about IORT at the University Hospital Heidelberg. Initially, he explains the background and study design of the INTRAGO phase 3 study.
This trial is actively recruiting and will report the results in the next few years.
Dr Giordano then talks about IORT at his institute. He discusses multidisciplinary collaboration, the method of IORT usage, and tumour types that are treated with it.
He concludes by giving advice on best practices with IORT.
Laser oncosurgery - A new perspective in treating cancer
Powering equity in cancer care through digital health
The advantages of IORT for early breast cancer treatment
Intraoperative radiotherapy treatment in the Philippines
Global adoption of single-shot targeted IORT for breast cancer
IORT at Institute Paoli-Calmettes in France
IORT at hospital Del Mar Barcelona in Spain
IORT at University Hospital Augsburg in Germany
IORT at Fortis Hospital Bangalore in India
